US$ 29.69
bio lab bpc-157 ARG 200 mcg, 60 caps BPC-157 Peptide | BPC-157 Synthetic
Description
The clinical use track record in Eastern Europe and Asia provides a level of real-world safety and efficacy data that purely preclinical peptides lack, though large-scale randomized controlled trials specifically for peripheral neuropathy are still needed

Being part of CBTS provided the support and scientific community that helped move this research forward. You can read the full study here: An MIEN1-based hexamer peptide (LA3IK) inhibits EGF-driven oncogenic signaling in prostate cancer by disrupting EGFRERBB2 heterodimerization

Molecular weight approximately 1419.53 Da

The levels of B12 and folate in serum were normal in these patients, but the haemodialysis period was in a very wide range

Jiang, H
